Koyfin Home > Directory > Health Care > Amag Pharmaceuticals > Total Revenue

Amag Pharmaceuticals Total Revenue Chart (AMAG)

Amag Pharmaceuticals annual/quarterly Total Revenue from 2010 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Amag Pharmaceuticals Total Revenue for the quarter ending June 06, 2020 was $53m a -59.47% decrease of -31m year over year
  • Amag Pharmaceuticals Total Revenue for the last 12 months ending June 06, 2020 was $298m a -9.34% decrease of -28m year over year
  • Amag Pharmaceuticals Annual Total Revenue for 2019 was $327m a -44.56% decrease of -146m from 2018
  • Amag Pharmaceuticals Annual Total Revenue for 2018 was $472m a -4.64% decrease of -22m from 2017
  • Amag Pharmaceuticals Annual Total Revenue for 2017 was $494m a 12.45% increase of 61m from 2016
Other Income Statement Metrics:
  • Amag Pharmaceuticals EBITDA for the quarter ending December 12, 2018 was $0m a -35,031.33% decrease of -29m year over year
  • Amag Pharmaceuticals Net Income for the quarter ending December 12, 2018 was $-22m a -143.49% increase of 32m year over year
View Chart On Koyfin

Quarterly AMAG Total Revenue Data

06/2020$53m
03/2020$70m
12/2019$89m
09/2019$84m
06/2019$78m
03/2019$76m
12/2018$86m
09/2018$122m
06/2018$146m
03/2018$117m

Annual AMAG Total Revenue Data

2019$327m
2018$472m
2017$494m
2016$432m
2015$418m
2014$124m
2013$81m
2012$85m
2011$61m
2010$66m